Team:HKU HongKong/Data/Bio Bricks.html

From 2012.igem.org

(Difference between revisions)
(Created page with "<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr"> <head> <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> <meta name="generat...")
 
(22 intermediate revisions not shown)
Line 8: Line 8:
<link rel="copyright" href="http://creativecommons.org/licenses/by/3.0/" />
<link rel="copyright" href="http://creativecommons.org/licenses/by/3.0/" />
<link rel="alternate" type="application/atom+xml" title="2011.igem.org Atom feed" href="/wiki/index.php?title=Special:RecentChanges&amp;feed=atom" /> <title>Team:HKU Hong Kong - 2012</title>
<link rel="alternate" type="application/atom+xml" title="2011.igem.org Atom feed" href="/wiki/index.php?title=Special:RecentChanges&amp;feed=atom" /> <title>Team:HKU Hong Kong - 2012</title>
-
<style type="text/css" media="screen, projection">/*<![CDATA[*/
+
<style type="text/css" media="screen, projection">
 +
/*<![CDATA[*/
@import "/wiki/skins/common/shared.css?270";
@import "/wiki/skins/common/shared.css?270";
@import "/wiki/skins/igem/main.css?270";
@import "/wiki/skins/igem/main.css?270";
-
/*]]>*/</style>
+
/*]]>*/
 +
</style>
<link rel="stylesheet" type="text/css" media="print" href="/wiki/skins/common/commonPrint.css?270" />
<link rel="stylesheet" type="text/css" media="print" href="/wiki/skins/common/commonPrint.css?270" />
<script>
<script>
Line 66: Line 68:
         <link rel='stylesheet' type='text/css' href='/common/table_styles.css' />
         <link rel='stylesheet' type='text/css' href='/common/table_styles.css' />
         <link rel='stylesheet' type='text/css' href='/forum/forum_styles.css' />
         <link rel='stylesheet' type='text/css' href='/forum/forum_styles.css' />
-
<script type='text/javascript'        src ='/forum/forum_scripts.js'></script>
+
    <script type='text/javascript'        src ='/forum/forum_scripts.js'></script>
</head>               
</head>               
Line 278: Line 280:
width: 1014px;
width: 1014px;
height: 10px;
height: 10px;
-
background: url(https://static.igem.org/mediawiki/2012/f/f1/HKU_tb_top.jpg) right bottom no-repeat #FFFFFF;
 
}
}
Line 290: Line 291:
width: 1014px;
width: 1014px;
padding: 0px 0px 0px 0px;
padding: 0px 0px 0px 0px;
-
background: #FFF;
+
background: url(https://static.igem.org/mediawiki/2012/6/68/HKU_tb_bg.gif) right repeat-y #FFFFFF;
margin: 0px 0px 0px 0px;
margin: 0px 0px 0px 0px;
}
}
Line 388: Line 389:
width: 417px;
width: 417px;
padding-top: 8px;}
padding-top: 8px;}
 +
 +
#footer{
 +
height: 50px;
 +
width: 100%;
 +
font-size: 12px;
 +
color: #008B00;
 +
text-align: center;
 +
clear:both;
 +
padding: 13px 0px 0px 0px;
 +
}
#main #header #buttons p {
#main #header #buttons p {
Line 435: Line 446:
<style>
<style>
-
#footer-box {
+
#footer-box{
-
  position: relative;
+
        position: relative;
-
  top:1000px;
+
        top:2150px;
-
  left: 0px;
+
-
  color: #000000;
+
-
  width:900px;}
+
}
}
</style>
</style>
</head>
</head>
 +
 +
<body>
<body>
<body>
<div id="main">
<div id="main">
Line 450: Line 460:
   <div id="header">
   <div id="header">
<div id="buttons">
<div id="buttons">
-
       <p><img src="https://static.igem.org/mediawiki/2012/0/0e/HKU_logo.fw.jpg" alt="logo_HKU" width="859" height="160" /></p>
+
       <p><img src="https://static.igem.org/mediawiki/igem.org/5/5d/Wiki_Wide_Band.jpg" alt="logo_HKU" width="859" height="160" /></p>
       <p>&nbsp;</p>
       <p>&nbsp;</p>
Line 471: Line 481:
     <li class="topmenu"><a href="#" style="height:26px;line-height:26px;">&nbsp;&nbsp;Data&nbsp;&nbsp;</a>
     <li class="topmenu"><a href="#" style="height:26px;line-height:26px;">&nbsp;&nbsp;Data&nbsp;&nbsp;</a>
     <ul>
     <ul>
-
    <li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Protocols.html">Protocols</a></li></font>
+
<li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Weekly_Notebook.html">Weekly Notebook</a></li></font>
-
<li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Weekly_Notebook.html">Weekly Notebook</a></li></font>
+
       <li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Bio_Bricks.html">Bio Bricks</a></li></font>
       <li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Bio_Bricks.html">Bio Bricks</a></li></font>
<li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Results.html">Results</a></li></font>
<li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Results.html">Results</a></li></font>
         </ul>
         </ul>
     </li>
     </li>
 +
    <li class="topmenu"><a href="#" style="height:26px;line-height:26px;">&nbsp;&nbsp;Protocols&nbsp;&nbsp;</a>
 +
      <ul>
 +
    <li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/Mol_Protocols.html">&nbsp;Molecular Cloning&nbsp;</a></li></font>
 +
<li><font size="10"><a href="https://2012.igem.org/Team:HKU_HongKong/Data/pvdQ_Protocols.html">&nbsp;pvdQ Expression Analysis&nbsp;</a></li></font>
 +
</ul>
 +
</li>
<li class="topmenu"><a href="https://2012.igem.org/Team:HKU_HongKong/Safety.html" style="height:26px;line-height:26px;">&nbsp;&nbsp;Safety&nbsp;&nbsp;</a></li>     
<li class="topmenu"><a href="https://2012.igem.org/Team:HKU_HongKong/Safety.html" style="height:26px;line-height:26px;">&nbsp;&nbsp;Safety&nbsp;&nbsp;</a></li>     
-
    <li class="topmenu"><a href="https://2012.igem.org/Team:HKU_HongKong/Attributions.html" style="height:26px;line-height:26px;">&nbsp;&nbsp;Attributions&nbsp;&nbsp;</a></li>
+
     <li class="toplast"><a href="https://2012.igem.org/Team:HKU_HongKong/Human_Practice.html" style="height:26px;line-height:26px;">&nbsp;&nbsp;Human Practice&nbsp;&nbsp;</a></li>
-
     <li class="toplast"><a href="https://2012.igem.org/Team:HKU_HongKong/Human_Practise.html" style="height:26px;line-height:26px;">&nbsp;&nbsp;Human Practise&nbsp;&nbsp;</a></li>
+
</ul>
</ul>
<p>&nbsp;</p>
<p>&nbsp;</p>
-
<h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px">
+
<p style="text-align: justify">&nbsp;</p>
-
<span style="font-weight: 400; text-decoration:underline">
+
<h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px">
-
<font face="Trebuchet MS" size="6">Abstract</font></span></h2>
+
<span style="font-weight: 400; text-decoration: underline">
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
<font face="Trebuchet MS" size="6">Bio-bricks:</font></span></h2>
-
&nbsp;</p>
+
<p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
&nbsp;</p>
-
HKU’s iGEM team aims to introduce
+
<h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left">
-
an acyl homoerine lactone (AHL)-degrading genetic system into the non-biolfilm-forming
+
<span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: rgb(255, 255, 255)">
-
and non-virulent BL21 Escherichia coli strain. PvdQ, an enzyme naturally
+
1)</span><span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none; ">
-
produced by Pseudomonas aeruginosa, is an acylase that functions to
+
</span><font face="Tahoma" size="2"><b>Constitutive Promoter (J23119) + Ribosomal
-
degrade long chain AHLs that bacteria like Pseudomonas putida or
+
Binding Site (B0034) + pvdQ Gene + Double Terminator (B0015)</b></font></h2>
-
aeruginosa itself utilize for biofilm formation. Biofilms are population
+
<p style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left">
-
density-dependent structures formed by quorum sensing bacteria that
+
<img border="0" src="https://static.igem.org/mediawiki/2012/2/27/1_biobrick.jpg" width="676" height="157"></p>
-
produce and secrete auto-inducers, which signal selective gene
+
<p style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left">
-
transcription. These signaling molecules, namely the AHLs, are
+
&nbsp;</p>
-
responsible for most bacterial pathogenicity including the opportunistic
+
<p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
-
respiratory infections caused by P.aeuroginosa in immunocompromised
+
This biobrick was constructed to test the
-
patients. </p>
+
expression of the pvdQ gene amplified by PCR from genomic DNA of Pseudomonas
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
aeruginosa. It is an uncontrollable, standard biobrick that can later be used as  
-
As a step towards combating these infections, E.coli can be effectively
+
a baseline reference to test whether our future biobricks result in an
-
used as a protein factory to maximize pvdQ yield in vitro or ex vivo.
+
improvement in pvdQ expression level.&nbsp; The biobrick is a composite part
-
Our most preliminary biobrick is a constitutive promoter that drives
+
consisting of the already prevalent Constitutive Promoter [2006 Berkley], along
-
baseline, exponential expression of pvdQ. This genetic pathway is
+
with the newly inserted pvdQ gene. It is also composed of a strong RBS and a
-
advantageous because the pvdQ gene is constitutively transcribed
+
transcription double terminator.&nbsp;</font>
-
regardless of environmental and endogenous factors.&nbsp; </p>
+
<p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
<b>Constitutive Promoter (J23119):</b>
-
<font color="#232323">&nbsp;This synthetic genetic pathway is an auto-inductive system where pvdQ
+
This promoter biobrick is the consensus sequence and therefore results in the  
-
protein production will specifically depend on the presence of N-dodecanoyl-L-Homoserine
+
idealized transcription scenario. Since it is a strong promoter and is
-
lactone and its coupling to the LuxR protein. Furthermore, several
+
constitutively expressed, it complies with our preliminary goal of testing
-
derivatives of the genetic system design can desirably optimize pvdQ
+
transcription and translation of the pvdQ gene in an AHL-independent manner<br>
-
yield. For instance, implementation of a positive feedback loop will
+
<br>
-
upregulate luxR production by the simple placement of the luxR gene  
+
<br>
-
downstream of PluxR Larger amounts of luxR will therefore bind a greater
+
</span><span style="font-size: 10pt; font-family: Tahoma">2) </span></font>
-
number of AHL molecules secreted by P.aeuroginosa biofilms, thereby
+
<font color="#232323" size="2" face="Tahoma"><b>LacI Promoter, RBS, LuxR Gene,  
-
activating the acylase gene’s expression at a low cell density. Hence,  
+
Double Terminator, LuxR Promoter, &amp; RBS (K137076) + pvdQ Gene + Double
-
the final biobrick produced by iGEM HKU is an AHL-inducible acylase
+
Terminator (B0015) </b> </font>
-
system. </font> </p>
+
<h2 style="text-align: justify"></h2>
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
<p style="text-align: justify">
-
&nbsp;Although the synthetic E.coli cannot be introduced into infected humans
+
<img border="0" src="https://static.igem.org/mediawiki/2012/0/0a/2_biobrick.jpg" width="935" height="182"></p>
-
or soil and water (sources of P.aueroginosa) itself, it can be used to
+
<p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
-
mass-produce pvdQ which can then be packaged into small protein-delivery
+
This biobrick was constructed to test the expression of the pvdQ gene in an environment containing the 3OC<sub>12</sub>-HSL
-
bores. These structures can be stimulated to efficiently release pvdQ at
+
substrate. However, the synthesis of pvdQ is not exclusively dependent on AHL.
-
the desired location, mimicking conventional drug-delivery systems.  
+
This is because the LacI+pI promoter that initiates transcription of the LuxR
-
While the mechanism of pvdQ delivery will not be addressed, it can be
+
gene can be effectively induced by IPTG. Moreover, the LuxR promoter is also
-
regarded as a potential implication of HKU’s iGEM project.
+
expressed well in the absence of LuxR and AHL. The biobrick is composed part of
-
 
+
the already existing K137076 [2008 Caltech] as well as the pvdQ gene and double
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
terminator sequence. The first 1,096bp of the K237076 biobrick containing the
-
&nbsp;<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
+
LacI and LuxR promoters, two RBS, and the LuxR gene was amplified using the
-
<u><font face="Trebuchet MS">
+
standard Prefix primer and a newly designed Suffix primer. </p>
-
<b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials
+
<p style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
-
&amp; </font></font><font face="Trebuchet MS" size="6" color="#232323">
+
We chose the biobrick K137076 to
-
Methods</font></u></p>
+
ligate to the pvdQ gene for the following reasons: </font></p>
-
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
+
<ul>
-
<i>
+
<li>
-
<font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p>
+
<p style="text-align: justify">
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">pvdQ was amplified from genomic DNA of Pseudomonas
+
<font size="2" face="Tahoma" color="#232323">&nbsp;K137076
-
Aeruginosa. A functional biobrick is constructed by combining pvdQ and
+
consists of a strong, continually expressed promoter (R0011) that can,
-
some regulatory elements (such as promoter and terminator). The
+
however, be further induced by IPTG. Such a promoter allows us to control
-
regulatory components are obtained from the iGEM Distribution Kit 2012.
+
the expression of the LuxR protein. &nbsp;<br>
-
As a result, a variety of pvdQ regulatory systems can be established.
+
&nbsp;</font></li>
-
Among the various regulation systems, the luxR regulation system is most
+
<li>
-
concerned. luxR is a gene that can encode LuxR which binds with AHLs and
+
<p style="text-align: justify">
-
upregulates the luxRp. As a result, in our biobrick model, the
+
<font size="2" face="Tahoma" color="#232323">The complex formed when two
-
expression of pvdQ will be upregulated. Increase in production of pvdQ
+
molecules of LuxR bind to two molecules of AHL, attaches to a palindromic
-
indicates an increase in acylase activity, which further degrades AHLs.
+
site on the pLuxR to transcribe the pvdQ gene.This pLuxR promoter however
-
The product biobrick will be a AHL-inducible acylase system. PvdQ will
+
causes leaky expression of pvdQ as it can be induced even in the absence of
-
only be produced w</font></font><font size="2" color="#232323">hen AHL is present.</font></font></p>
+
LuxR and AHL. <br>
-
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
+
&nbsp;</font></li>
-
<font color="#232323"><i>Testing the inhibitory effect</i></font></p>
+
</ul>
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">The growth rate of monospecies biofilm of <i>
+
<p class="MsoNormal" style="text-align: justify">
-
Pseudomonas putida</i> is used to reflect the inhibitory effect of
+
<font size="2" face="Tahoma" color="#232323">&nbsp;</font><font color="#232323"><span style="font-size: 10pt; font-family: Tahoma"><br>
-
engineered <i>Escherichia coli</i>. This is because the major AHLs
+
</span><b><font size="2" face="Tahoma">3). Constitutive </font></b>
-
secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by
+
<span style="font-size: 10pt; font-family: Tahoma">Promoter</span><b><font size="2" face="Tahoma">  
-
PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the
+
(pLacI) + Ribosomal Binding Site + LuxR Gene + Double Terminator + LuxR Promoter
-
pathogenic microorganism. <i>pvdQ</i> expressing E. coli will be mixed
+
(J09855) + Ribosomal Binding Site (B0034) + pvdQ Gene + Double Terminator
-
with Pseudomonas putida and grown on agar plate. The reduction in
+
(B0015)</font></b></font></p>
-
biofilm formation will be assayed by crystal violet assay. The next part
+
<p class="MsoNormal" style="text-align: justify">
-
of the experiment is to add engineered E. coli to different
+
<img border="0" src="https://static.igem.org/mediawiki/2012/6/6d/3_biobrick.jpg" width="945" height="184"></p>
-
phases of biofilm to validate the role of AHLs in biofilm formation.</font></p>
+
<p style="text-align:justify;text-justify:inter-ideograph">
 +
<font size="2" face="Tahoma" color="#232323">This biobrick was constructed such
 +
that</font></p>
 +
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
 +
<br>
 +
&nbsp;</p>
 +
<p class="MsoNormal" style="text-align: left"><b>
 +
<font size="2" face="Tahoma" color="#232323">4). </font>
 +
<font size="2" face="Tahoma" color="#232323">LuxR Promoter (R1062) + Ribosomal
 +
Binding Site, LuxR Gene, Double Terminator, &amp; Ribosomal Binding Site (amplified
 +
from K137076) + pvdQ Gene + Double Terminator (B0015)</font></b></p>
 +
<p class="MsoNormal" style="text-align: left">
 +
<img border="0" src="https://static.igem.org/mediawiki/2012/8/87/4_biobricks.jpg" width="864" height="173"></p>
 +
<p style="text-align: justify; text-justify: inter-ideograph">
 +
<font face="Tahoma" size="2" color="#232323"><br>
 +
This final biobrick is entirely an AHL-dependent system, as an identical
 +
promoter controls the transcription and translation of both the LuxR and the
 +
pvdQ gene. This LuxR promoter, unlike its Bba_R0062 counterpart, is only weakly
 +
expressed in the absence of LuxR and AHL. However, a desirable positive feedback
 +
mechanism is generated upon coupling of AHL with the LuxR protein. &nbsp;The AHL-LuxR
 +
complex binds to p<sub>LuxR</sub> and upregulates gene expression. As more LuxR
 +
is expressed, subsequent pairing of the molecules further activates the
 +
promoter. Thereby, a large yield of pvdQ is obtainable at low cell density. The
 +
outcome is advantageous as biofilm formation can be interrupted at an early
 +
stage. &nbsp;</font></p>
 +
<p style="text-align:justify;text-justify:inter-ideograph">
 +
<font size="2" face="Tahoma" color="#232323">&nbsp;</font></p>
 +
<p class="MsoNormal">&nbsp;</p>
 +
<p style="text-align: justify">&nbsp;</p>
 +
<h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left">
 +
&nbsp;</h2>
 +
<h2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left">
 +
&nbsp;</h2>
</body>
</body>
-
 
</html>
</html>

Latest revision as of 13:30, 26 September 2012

Team:HKU Hong Kong - 2012

Team:HKU HK

From 2011.igem.org